SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 38 filers reported holding SPRING BK PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,000 | -87.1% | 12,186 | -77.5% | 0.00% | – |
| Q4 2019 | $85,000 | -75.7% | 54,066 | -46.0% | 0.00% | -100.0% |
| Q3 2019 | $350,000 | -55.5% | 100,077 | -53.1% | 0.00% | 0.0% |
| Q2 2019 | $787,000 | -44.2% | 213,188 | +132.6% | 0.00% | -50.0% |
| Q1 2018 | $1,410,000 | +108.6% | 91,663 | +82.3% | 0.00% | +100.0% |
| Q4 2017 | $676,000 | -0.1% | 50,291 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $677,000 | +16.9% | 49,994 | -23.1% | 0.00% | 0.0% |
| Q1 2017 | $579,000 | – | 65,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 785,950 | $9,314,000 | 0.91% |
| Morse Asset Management, Inc | 177,500 | $2,103,000 | 0.58% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 281,213 | $3,332,000 | 0.38% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $860,000 | 0.33% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,883,000 | 0.31% |
| Private Capital Advisors, Inc. | 52,335 | $620,000 | 0.19% |
| SECTORAL ASSET MANAGEMENT INC | 131,656 | $1,560,000 | 0.17% |
| Lee Financial Co | 18,750 | $222,000 | 0.05% |
| Baker Brothers Advisors | 373,144 | $4,422,000 | 0.03% |
| Alyeska Investment Group, L.P. | 200,000 | $2,370,000 | 0.02% |